Condition
Ulcerative Colitis Chronic Severe
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (2)
P 2 (2)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06420492Phase 2Recruiting
Study of Novel Therapeutics for Acute Remedy of Colitis
NCT05912712Phase 1Unknown
Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum for the Topical Treatment of Rectal Mucosal Ulcers
NCT04504383Phase 2Completed
PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
NCT05735665Not ApplicableUnknown
Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative Colitis
NCT04353791Phase 1Completed
Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis
Showing all 5 trials